IBSA PHARMA INC

FDA Regulatory Profile

Summary

Total Recalls
15
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0341-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL; 6 pouches x 5 ampules, Rx OnlyJanuary 30, 2023
D-0335-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL; 6 pouches x 5 ampules, Rx OnlyJanuary 30, 2023
D-0337-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL; 6 pouches x 5 ampules, Rx OnlJanuary 30, 2023
D-0332-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL; 6 pouches x 5 ampules, Rx OnlJanuary 30, 2023
D-0333-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL; 6 pouches x 5 ampules, Rx OnJanuary 30, 2023
D-0343-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL; 6 pouches x 5 ampules, Rx OnlJanuary 30, 2023
D-0339-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx OnJanuary 30, 2023
D-0345-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL; 6 pouches x 5 ampules, Rx OnlJanuary 30, 2023
D-0336-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL; 6 pouches x 5 ampules, Rx OnJanuary 30, 2023
D-0340-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL; 6 pouches x 5 ampules, Rx OnlyJanuary 30, 2023
D-0338-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL; 6 pouches x 5 ampules, Rx OnlyJanuary 30, 2023
D-0334-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx OnJanuary 30, 2023
D-0331-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL; 6 pouches x 5 ampules, Rx OnlyJanuary 30, 2023
D-0342-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL; 6 pouches x 5 ampules, Rx OnlJanuary 30, 2023
D-0344-2023Class IITIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5 ampules, Rx OnlJanuary 30, 2023